Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM).
Traynor BP, Fitzgerald S, Alfonso F, O'Kane P, Sabaté M, Tölg R, Trevelyan J, Hahn JY, Mylotte D, Wöhrle J, Rai H, Cortese B, Morice MC, Schuette D, Copt S, Oldroyd KG, Byrne RA; REFORM investigators. Traynor BP, et al. Among authors: copt s. Cardiovasc Revasc Med. 2023 Nov;56:75-81. doi: 10.1016/j.carrev.2023.06.004. Epub 2023 Jun 6. Cardiovasc Revasc Med. 2023. PMID: 37328392 Free article. Clinical Trial.
Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy.
Carrié D, Menown I, Oldroyd K, Copt S, Talwar S, Maillard L, Morice MC, Teik LS, Lang I, Urban P. Carrié D, et al. Among authors: copt s. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1633-1642. doi: 10.1016/j.jcin.2017.05.033. JACC Cardiovasc Interv. 2017. PMID: 28838473 Free article. Clinical Trial.
Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.
Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC; LEADERS FREE Investigators. Naber CK, et al. Among authors: copt s. Eur Heart J. 2017 Apr 1;38(13):961-969. doi: 10.1093/eurheartj/ehw203. Eur Heart J. 2017. PMID: 27190095 Free PMC article. Clinical Trial.
Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial.
Richardt G, Abdelghani M, Allali A, Toelg R, Abdellaoui M, Krackhardt F, Wiseth R, Morice MC, Copt S, Stoll HP, Urban P. Richardt G, et al. Among authors: copt s. Clin Res Cardiol. 2021 Feb;110(2):162-171. doi: 10.1007/s00392-020-01672-3. Epub 2020 May 21. Clin Res Cardiol. 2021. PMID: 32440723 Clinical Trial.
Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
Garot P, Brunel P, Dibie A, Morelle JF, Abdellaoui M, Levy R, Carrié D, Karsenty B, Robin C, Berland J, Copt S, Sadozai Slama S, Oldroyd K, Morice MC, Lipiecki J; BioFreedom France Investigators. Garot P, et al. Among authors: copt s. Catheter Cardiovasc Interv. 2023 Jan;101(1):60-71. doi: 10.1002/ccd.30481. Epub 2022 Nov 15. Catheter Cardiovasc Interv. 2023. PMID: 36378683
Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial.
Richardt G, Maillard L, Nazzaro MS, Abdel-Wahab M, Carrié D, Iñiguez A, Garot P, Abdellaoui M, Morice MC, Foley D, Copt S, Stoll HP, Urban P. Richardt G, et al. Among authors: copt s. Clin Res Cardiol. 2019 Jan;108(1):31-38. doi: 10.1007/s00392-018-1308-1. Epub 2018 Jun 27. Clin Res Cardiol. 2019. PMID: 29951803 Clinical Trial.
Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes.
Menown IBA, Mamas MA, Cotton JM, Hildick-Smith D, Eberli FR, Leibundgut G, Tresukosol D, Macaya C, Copt S, Slama SS, Oldroyd KG. Menown IBA, et al. Among authors: copt s. J Interv Cardiol. 2021 Apr 1;2021:6654515. doi: 10.1155/2021/6654515. eCollection 2021. J Interv Cardiol. 2021. PMID: 33880087 Free PMC article.
First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial.
Grundeken MJ, Wykrzykowska JJ, Ishibashi Y, Garg S, de Vries T, Garcia-Garcia HM, Onuma Y, de Winter RJ, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Meier B, Jüni P, Yazdani A, Copt S, Windecker S, Serruys PW. Grundeken MJ, et al. Among authors: copt s. Catheter Cardiovasc Interv. 2016 Jun;87(7):E248-60. doi: 10.1002/ccd.26344. Epub 2015 Dec 9. Catheter Cardiovasc Interv. 2016. PMID: 26649651 Clinical Trial.
Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial.
Mehran R, Chandrasekhar J, Urban P, Lang IM, Windhoevel U, Spaulding C, Copt S, Stoll HP, Morice MC; LEADERS FREE Investigators. Mehran R, et al. Among authors: copt s. JAMA Cardiol. 2020 Aug 1;5(8):939-947. doi: 10.1001/jamacardio.2020.0285. JAMA Cardiol. 2020. PMID: 32432718 Free PMC article. Clinical Trial.
35 results